Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 2
1964 1
1965 1
1967 3
1968 3
1969 3
1972 1
1973 5
1974 2
1977 1
1980 1
1981 2
1982 1
1983 3
1984 4
1985 5
1986 3
1987 2
1988 2
1989 3
1991 2
1992 1
1993 2
1994 2
1995 14
1996 11
1997 6
1998 12
1999 10
2000 5
2001 8
2002 11
2003 7
2004 14
2005 9
2006 14
2007 18
2008 11
2009 16
2010 25
2011 29
2012 26
2013 32
2014 39
2015 38
2016 34
2017 29
2018 42
2019 36
2020 48
2021 51
2022 38
2023 40
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Results by year

Filters applied: . Clear all
Page 1
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation.
Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AC, Fournier B, Hurkmans C, Lecouvet FE, Meattini I, Méndez Romero A, Ricardi U, Russell NS, Schanne DH, Scorsetti M, Tombal B, Verellen D, Verfaillie C, Ost P. Guckenberger M, et al. Lancet Oncol. 2020 Jan;21(1):e18-e28. doi: 10.1016/S1470-2045(19)30718-1. Lancet Oncol. 2020. PMID: 31908301 Review.
Proteome-wide structural changes measured with limited proteolysis-mass spectrometry: an advanced protocol for high-throughput applications.
Malinovska L, Cappelletti V, Kohler D, Piazza I, Tsai TH, Pepelnjak M, Stalder P, Dörig C, Sesterhenn F, Elsässer F, Kralickova L, Beaton N, Reiter L, de Souza N, Vitek O, Picotti P. Malinovska L, et al. Among authors: de souza n. Nat Protoc. 2023 Mar;18(3):659-682. doi: 10.1038/s41596-022-00771-x. Epub 2022 Dec 16. Nat Protoc. 2023. PMID: 36526727 Review.
Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART).
Maguire R, McCann L, Kotronoulas G, Kearney N, Ream E, Armes J, Patiraki E, Furlong E, Fox P, Gaiger A, McCrone P, Berg G, Miaskowski C, Cardone A, Orr D, Flowerday A, Katsaragakis S, Darley A, Lubowitzki S, Harris J, Skene S, Miller M, Moore M, Lewis L, DeSouza N, Donnan PT. Maguire R, et al. BMJ. 2021 Jul 21;374:n1647. doi: 10.1136/bmj.n1647. BMJ. 2021. PMID: 34289996 Free PMC article. Clinical Trial.
Delivering a Quantitative Imaging Agenda.
deSouza NM, van der Lugt A, Hall TJ, Sullivan D, Zahlmann G. deSouza NM, et al. Cancers (Basel). 2023 Aug 23;15(17):4219. doi: 10.3390/cancers15174219. Cancers (Basel). 2023. PMID: 37686495 Free PMC article.
Evolutionary determinants of curability in cancer.
Mansur MB, deSouza NM, Natrajan R, Abegglen LM, Schiffman JD, Greaves M. Mansur MB, et al. Nat Ecol Evol. 2023 Nov;7(11):1761-1770. doi: 10.1038/s41559-023-02159-w. Epub 2023 Aug 24. Nat Ecol Evol. 2023. PMID: 37620552 Review.
Editorial: Quantitative Imaging for Clinical Decisions.
deSouza NM, Oprea-Lager DE, Fournier LS. deSouza NM, et al. Front Oncol. 2022 Mar 3;12:858372. doi: 10.3389/fonc.2022.858372. eCollection 2022. Front Oncol. 2022. PMID: 35311084 Free PMC article. No abstract available.
668 results